NEW YORK – PerkinElmer on Tuesday said it has received the CE mark for a COVID-19 antigen test.
The PerkinElmer COVID-19 Antigen Test can be used to screen or help diagnose symptomatic and asymptomatic patients suspected of having the disease. It qualitatively detects SARS-CoV-2 nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens and provides results in as little as 15 minutes, the Waltham, Massachusetts-based company said, adding it has launched the test in more than 30 countries that accept CE marking.